Company Overview

Nanalysis Scientific Corp. is a Canadian technology company focused on scientific instrumentation, analytical services, and laboratory technologies. The company operates primarily in the nuclear magnetic resonance (NMR) spectroscopy market and related analytical instrumentation sectors, serving customers across academic research, industrial laboratories, pharmaceutical development, petrochemical analysis, food testing, and life sciences. Nanalysis is best known for developing compact, permanent-magnet NMR spectrometers designed to offer lower operating costs and portability compared with traditional superconducting NMR systems.

The company’s primary revenue drivers include sales of NMR instruments, recurring service and support contracts, laboratory services, and analytical testing operations through subsidiaries and acquisitions. Nanalysis has positioned itself as a provider of compact and benchtop analytical instrumentation that broadens access to NMR technology beyond large institutional laboratories. Founded in Canada and publicly listed on the TSX Venture Exchange and OTC markets, the company evolved from a specialized instrumentation developer into a broader scientific equipment and laboratory services platform through acquisitions and strategic expansion initiatives.

Business Operations

Nanalysis generates revenue through scientific instrument manufacturing, analytical laboratory services, maintenance contracts, and related technology solutions. Its operations include the development and commercialization of compact NMR spectrometers and integrated analytical systems. Key operating assets include proprietary permanent magnet technology, spectroscopy software platforms, and laboratory service capabilities. The company’s business structure has expanded through acquisitions, including operations associated with K’ Prime Technologies, RS2D, and laboratory service businesses that broaden its analytical instrumentation and recurring revenue exposure.

The company operates in both domestic Canadian markets and international markets across North America, Europe, and selected global regions. Its technologies are used in chemical analysis, process monitoring, petroleum characterization, pharmaceutical research, and educational environments. Nanalysis has pursued strategic relationships with distributors, industrial customers, and research institutions to expand commercial adoption of compact NMR systems. Public disclosures indicate that the company continues to emphasize recurring service revenue and cross-selling opportunities across its instrumentation and laboratory operations.

Strategic Position & Investments

Nanalysis has focused its strategy on expanding its analytical instrumentation platform through acquisitions, technology integration, and increased exposure to recurring revenue streams. Major investments have included the acquisition of K’ Prime Technologies, which strengthened the company’s presence in process analytical technology and industrial monitoring solutions, and RS2D, a France-based MRI and NMR electronics company that expanded the company’s technological capabilities and European footprint. These transactions were intended to deepen vertical integration and broaden product offerings in spectroscopy and imaging technologies.

The company has also emphasized growth in sectors requiring portable and lower-cost analytical instrumentation, including energy, pharmaceuticals, advanced materials, and industrial process control. Emerging areas of involvement include industrial automation for analytical testing and expanded software-enabled spectroscopy solutions. Management has publicly stated that its long-term strategy centers on building an integrated scientific instrumentation and laboratory services business with diversified revenue streams and international reach.

Geographic Footprint

Nanalysis is headquartered in Calgary, Alberta, Canada, and maintains operations and commercial activities across North America and Europe. Through acquisitions and distribution relationships, the company has expanded its operational footprint into international scientific and industrial markets. Its customer base includes academic institutions, industrial laboratories, energy companies, and pharmaceutical organizations in multiple regions.

The acquisition of RS2D significantly strengthened the company’s presence in France and broader European markets, while North America remains an important commercial region for instrumentation sales and analytical services. Public company disclosures and investor materials indicate that Nanalysis continues to pursue international growth opportunities through direct operations, channel partnerships, and technology commercialization efforts.

Leadership & Governance

Nanalysis was founded by scientists and entrepreneurs focused on commercializing compact NMR technology. The company’s leadership has emphasized innovation in accessible analytical instrumentation and strategic expansion through acquisitions. Corporate governance is overseen by a board of directors and executive management team with experience in scientific instrumentation, finance, engineering, and industrial technology sectors.

Key executives include:

• Sean Krakiwsky – President and Chief Executive Officer
• Michael Achtem – Chief Financial Officer
• Ming Xiao – Chief Technology Officer
• Ryan Riess – Executive Vice President, Corporate Development

Management has communicated a strategy centered on scaling recurring revenues, integrating acquired businesses, and positioning Nanalysis as a diversified scientific instrumentation and laboratory technology company. Public filings and investor communications consistently emphasize operational integration, technology commercialization, and international market expansion as core priorities.